Clinical and Epidemiologic Characteristics of Infants Hospitalized with Respiratory Syncytial Virus Infection During the 2022–2023 Season in Mexico-Reference-Cited by-同舟云学术

Clinical and Epidemiologic Characteristics of Infants Hospitalized with Respiratory Syncytial Virus Infection During the 2022–2023 Season in Mexico

Published:2023-06-22 Issue:10 Volume:42 Page:e382-e384
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Esparza-Miranda Luis A.¹,Juárez-Tobías Susana²^ORCID,Muñoz-Escalante Juan C.¹³^ORCID,Oliva-Jara Ulrik A.¹,Cadena-Mota Sandra¹,Wong-Chew Rosa M.⁴^ORCID,Noyola Daniel E.¹³^ORCID

Affiliation:

1. Microbiology Department, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México

2. Pediatrics Division, Hospital Central “Dr. Ignacio Morones Prieto,” San Luis Potosí, México

3. Center for Research in Health Sciences and Biomedicine, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México

4. División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.

Abstract

In 2022, several countries reported an increase in respiratory syncytial virus (RSV) infections. We assessed the clinical characteristics and outcomes of infants hospitalized with RSV and compared them with infants hospitalized between 2009 and 2015. No significant differences in underlying disorders, intensive care unit admission rates and mortality were observed suggesting currently circulating RSV strains do not show heightened virulence.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference7 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.;Li;Lancet,2022

2. Perturbations in respiratory syncytial virus activity during the SARS-CoV-2 pandemic.;Falsey;J Infect Dis,2022

3. Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic.;Reicherz;J Infect Dis,2022

4. Viral lineages in the 2022 RSV surge in the United States.;Adams;N Engl J Med,2023

5. Human metapneumovirus and other respiratory viral infections in children attending a day care center.;Montejano-Elías;Pediatr Infect Dis J,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus—tackling the burden of disease and implementing preventive solutions;Frontiers in Pediatrics;2024-07-31

2. Guía de práctica clínica mexicana para la prevención de infección por virus sincitial respiratorio en lactantes de alto riesgo;Acta Pediátrica de México;2024-07-25

3. Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of SARS-CoV-2 Can Be Attributed to Changes in Testing;Clinical Infectious Diseases;2024-04-11

4. Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing;2024-02-06